Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors

Authors:

Abstract
A series of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides were designed as the first class of highly selective ZAK inhibitors. The representative compound 3h strongly inhibits the kinase activity of ZAK with an IC50 of 3.3 nM and dose-dependently suppresses the activation of ZAK downstream signals in vitro and in vivo, while it is significantly less potent for the majority of 403 nonmutated kinases evaluated. Compound 3h also exhibits orally therapeutic effects on cardiac hypertrophy in a spontaneous hypertensive rat model.
Funding Information
  • Ministry of Health and Welfare (MOHW106-TDU- B-212- 113004)
  • National Center of Excellence for Clinical Trial and Research
  • Jinan University
  • National Natural Science Foundation of China (31270769, 81425021, 81673285)
  • Guangzhou City (201508030036)
  • Guangdong Province (2013A022100038, 2015A030306042, 2015A030312014, 2016A050502041)

This publication has 27 references indexed in Scilit: